Trial Profile
Drug Interaction Study of Henagliflozin and Retagliptin in Healthy Subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Jul 2017
Price :
$35
*
At a glance
- Drugs Henagliflozin (Primary) ; Retagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Jiangsu Hengrui Medicine Co.
- 20 Jul 2015 New trial record